Clinical Trial Update: A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE) and Sjogren's Disease (SjD) [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating intravenous ABBV-319 in adults with systemic lupus erythematosus and Sjögren's syndrome, focusing on adverse events, pharmacokin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome
• Systemic Lupus Erythematosus

Drugs mentioned

• ABBV-319

Snippet

Sponsor: AbbVie | Conditions: Dry Eye Syndrome, Systemic Lupus Erythematosus | Phase 1 | Status: RECRUITING